Position in BDSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$334,805
+$334,805 QoQ
Shares Held
23,090
Ownership
0.228%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 40 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in BDSX
reported options exposure · as of Mar 31, 2026CallValue
$214,600
CallShares
14,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $220,999,669 across 38 Diagnostics & Research names. BDSX ranks #33 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
240,547 | $45,607,710 | |
| 2 | NTRA |
Natera, Inc.
|
199,638 | $39,925,603 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
64,399 | $31,654,039 | |
| 4 | GRAL |
GRAIL, Inc.
|
304,808 | $15,752,477 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
14,061 | $7,900,735 | |
| 6 | QGEN |
Qiagen N.V.
|
185,900 | $7,443,436 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
42,781 | $7,295,871 | |
| 8 | GH |
Guardant Health, Inc.
|
75,989 | $7,019,103 |
All Filings in BDSX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214,600 | 14,800 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $334,805 | 23,090 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $85,000 | 12,500 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $120,800 | 16,000 | Call | Other | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||